Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mauricio Urquiza

Intratumoral Injection of Ad-Isf35 (Chimeric CD154) Breaks Tolerance and Induces Lymphoma Tumor Regression

Human Gene Therapy

English

Related publications

Intratumoral Injection of an Adenovirus Expressing Interleukin 2 Induces Regression and Immunity in a Murine Breast Cancer Model.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1995

English

Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients With Merkel Cell Carcinoma

Clinical Cancer Research

Cancer Research

Oncology

2018

English

Intratumoral Treatment of One Tumor Lesion With LTX-315 Induces Complete Tumor Regression and Long-Term Specific Protective Immune Responses in a Metastatic Rodent Tumor Model

Journal for ImmunoTherapy of Cancer

English

Targeting xCT, a Cystine-Glutamate Transporter Induces Apoptosis and Tumor Regression for KSHV/HIV-associated Lymphoma

Journal of Hematology and Oncology

English

Genetic Immunization With a Melanocytic Self-Antigen Linked to Foreign Helper Sequences Breaks Tolerance and Induces Autoimmunity and Tumor Immunity

English

Intratumoral Injection of STING Ligand Promotes Abscopal Effect

Journal for ImmunoTherapy of Cancer

English

A Recombinant Chimeric Protein Specifically Induces Mutant KRAS Degradation and Potently Inhibits Pancreatic Tumor Growth

Oncotarget

Oncology

2016

English

Mast Cell Degranulation Breaks Peripheral Tolerance

American Journal of Transplantation

English

Correction: Therapeutic Peptide Vaccine-Induced CD8 T Cells Strongly Modulate Intratumoral Macrophages Required for Tumor Regression

Cancer immunology research

Cancer Research

Immunology

2015

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mauricio Urquiza

Intratumoral Injection of Ad-Isf35 (Chimeric CD154) Breaks Tolerance and Induces Lymphoma Tumor Regression

Related publications

Intratumoral Injection of an Adenovirus Expressing Interleukin 2 Induces Regression and Immunity in a Murine Breast Cancer Model.

Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients With Merkel Cell Carcinoma

Intratumoral Treatment of One Tumor Lesion With LTX-315 Induces Complete Tumor Regression and Long-Term Specific Protective Immune Responses in a Metastatic Rodent Tumor Model

Targeting xCT, a Cystine-Glutamate Transporter Induces Apoptosis and Tumor Regression for KSHV/HIV-associated Lymphoma

Genetic Immunization With a Melanocytic Self-Antigen Linked to Foreign Helper Sequences Breaks Tolerance and Induces Autoimmunity and Tumor Immunity

Intratumoral Injection of STING Ligand Promotes Abscopal Effect

A Recombinant Chimeric Protein Specifically Induces Mutant KRAS Degradation and Potently Inhibits Pancreatic Tumor Growth

Mast Cell Degranulation Breaks Peripheral Tolerance

Correction: Therapeutic Peptide Vaccine-Induced CD8 T Cells Strongly Modulate Intratumoral Macrophages Required for Tumor Regression